Study S002495

Effect of Behavioral Intervention/Therapy to Reduce Diabetes and Liver Disease Risk Through Prescribed Digital Therapeutics Enabled by AI/ML Powered Predictive Analytics

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07032311
Acronym: SIPPA-QH_HHC-2
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 180
Start: 2026-08-20
Primary completion: 2027-10-30
Lead sponsor: SIPPA Solutions INC
Conditions: Type 2 Diabetes; Liver Disease
Interventions: DEVICE:Behavioral Treatment
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Change in Glycated Hemoglobin (HbA1c) [Baseline to 6 months after randomization]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.